Company Name:DexCom, Inc.
CEO: Kevin Ronald Sayer

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.


Key numbers

Market Capitalization:39438659892
Shares Outstanding: 92344900
Float: 90871999
Next Earning Date:2020-11-04
TTm EPS: 2.224
TTm Dividend Rate:
200 days moving average:285.83
50 days moving average: 400.51
One day percent Change: 1.87



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,